Literature DB >> 32669023

D-Glucose uptake and clearance in the tauopathy Alzheimer's disease mouse brain detected by on-resonance variable delay multiple pulse MRI.

Lin Chen1,2, Zhiliang Wei1,2, Kannie Wy Chan2,3, Yuguo Li1,2, Kapil Suchal4, Sheng Bi4, Jianpan Huang3, Xiang Xu1,2, Philip C Wong4,5, Hanzhang Lu1,2, Peter Cm van Zijl1,2, Tong Li4, Jiadi Xu1,2.   

Abstract

In this study, we applied on-resonance variable delay multiple pulse (onVDMP) MRI to study D-glucose uptake in a mouse model of Alzheimer's disease (AD) tauopathy and demonstrated its feasibility in discriminating AD mice from wild-type mice. The D-glucose uptake in the cortex of AD mice (1.70 ± 1.33%) was significantly reduced compared to that of wild-type mice (5.42 ± 0.70%, p = 0.0051). Also, a slower D-glucose uptake rate was found in the cerebrospinal fluid (CSF) of AD mice (0.08 ± 0.01 min-1) compared to their wild-type counterpart (0.56 ± 0.1 min-1, p < 0.001), which suggests the presence of an impaired glucose transporter on both blood-brain and blood-CSF barriers of these AD mice. Clearance of D-glucose was observed in the CSF of wild-type mice but not AD mice, which suggests dysfunction of the glymphatic system in the AD mice. The results in this study indicate that onVDMP MRI could be a cost-effective and widely available method for simultaneously evaluating glucose transporter and glymphatic function of AD. This study also suggests that tau protein affects the D-glucose uptake and glymphatic impairment in AD at a time point preceding neurofibrillary tangle pathology.

Entities:  

Keywords:  Alzheimer’s diseases; Glucose uptake; chemical exchange saturation transfer; dynamic glucose enhanced; on-resonance variable delay multiple pulse; tau pathology

Year:  2020        PMID: 32669023      PMCID: PMC8054725          DOI: 10.1177/0271678X20941264

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  59 in total

1.  High-resolution creatine mapping of mouse brain at 11.7 T using non-steady-state chemical exchange saturation transfer.

Authors:  Lin Chen; Zhiliang Wei; Shuhui Cai; Yuguo Li; Guanshu Liu; Hanzhang Lu; Robert G Weiss; Peter C M van Zijl; Jiadi Xu
Journal:  NMR Biomed       Date:  2019-08-28       Impact factor: 4.044

2.  Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

3.  T1ρ-weighted Dynamic Glucose-enhanced MR Imaging in the Human Brain.

Authors:  Daniel Paech; Patrick Schuenke; Christina Koehler; Johannes Windschuh; Sibu Mundiyanapurath; Sebastian Bickelhaupt; David Bonekamp; Philipp Bäumer; Peter Bachert; Mark E Ladd; Martin Bendszus; Wolfgang Wick; Andreas Unterberg; Heinz-Peter Schlemmer; Moritz Zaiss; Alexander Radbruch
Journal:  Radiology       Date:  2017-06-16       Impact factor: 11.105

4.  Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.

Authors:  Ron Brookmeyer; Nada Abdalla; Claudia H Kawas; María M Corrada
Journal:  Alzheimers Dement       Date:  2017-12-07       Impact factor: 21.566

5.  Vitamin E and donepezil for the treatment of mild cognitive impairment.

Authors:  Ronald C Petersen; Ronald G Thomas; Michael Grundman; David Bennett; Rachelle Doody; Steven Ferris; Douglas Galasko; Shelia Jin; Jeffrey Kaye; Allan Levey; Eric Pfeiffer; Mary Sano; Christopher H van Dyck; Leon J Thal
Journal:  N Engl J Med       Date:  2005-04-13       Impact factor: 91.245

6.  Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.

Authors:  Feng Luo; Nathan R Rustay; Ulrich Ebert; Vincent P Hradil; Todd B Cole; Daniel A Llano; Sarah R Mudd; Yumin Zhang; Gerard B Fox; Mark Day
Journal:  Neurobiol Aging       Date:  2010-10-18       Impact factor: 4.673

7.  In vivo proton spectroscopy and spectroscopic imaging of [1-13C]-glucose and its metabolic products.

Authors:  P C van Zijl; A S Chesnick; D DesPres; C T Moonen; J Ruiz-Cabello; P van Gelderen
Journal:  Magn Reson Med       Date:  1993-11       Impact factor: 4.668

8.  Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer.

Authors:  Xiang Xu; Kannie W Y Chan; Linda Knutsson; Dmitri Artemov; Jiadi Xu; Guanshu Liu; Yoshinori Kato; Bachchu Lal; John Laterra; Michael T McMahon; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2015-09-25       Impact factor: 4.668

9.  Natural D-glucose as a biodegradable MRI relaxation agent.

Authors:  Nirbhay N Yadav; Jiadi Xu; Amnon Bar-Shir; Qin Qin; Kannie W Y Chan; Ksenija Grgac; Wenbo Li; Michael T McMahon; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2014-06-27       Impact factor: 4.668

10.  Arterial Input Functions and Tissue Response Curves in Dynamic Glucose-Enhanced (DGE) Imaging: Comparison Between glucoCEST and Blood Glucose Sampling in Humans.

Authors:  Linda Knutsson; Anina Seidemo; Anna Rydhög Scherman; Karin Markenroth Bloch; Rita R Kalyani; Mads Andersen; Pia C Sundgren; Ronnie Wirestam; Gunther Helms; Peter C M van Zijl; Xiang Xu
Journal:  Tomography       Date:  2018-12
View more
  10 in total

1.  Cerebrospinal fluid-tissue exchange revealed by phase alternate labeling with null recovery MRI.

Authors:  Anna M Li; Jiadi Xu
Journal:  Magn Reson Med       Date:  2021-11-19       Impact factor: 4.668

2.  Quantitative kinetic modelling and mapping of cerebral glucose transport and metabolism using glucoCESL MRI.

Authors:  Ben R Dickie; Tao Jin; Ping Wang; Rainer Hinz; William Harris; Hervé Boutin; Geoff Jm Parker; Laura M Parkes; Julian C Matthews
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-23       Impact factor: 6.960

Review 3.  Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress.

Authors:  Nicole G Rummel; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2021-12-21       Impact factor: 7.468

4.  Characterizing region-specific glucose metabolic profile of the rodent brain using Seahorse XFe96 analyzer.

Authors:  Linshu Wang; Kiran Chaudhari; Ali Winters; Yuanhong Sun; Ran Liu; Shao-Hua Yang
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-25       Impact factor: 6.960

5.  Age-dependent cerebrospinal fluid-tissue water exchange detected by magnetization transfer indirect spin labeling MRI.

Authors:  Anna M Li; Lin Chen; Hongshuai Liu; Yuguo Li; Wenzhen Duan; Jiadi Xu
Journal:  Magn Reson Med       Date:  2021-12-27       Impact factor: 4.668

6.  Deuterium metabolic imaging in the human brain at 9.4 Tesla with high spatial and temporal resolution.

Authors:  Loreen Ruhm; Nikolai Avdievich; Theresia Ziegs; Armin M Nagel; Henk M De Feyter; Robin A de Graaf; Anke Henning
Journal:  Neuroimage       Date:  2021-10-09       Impact factor: 6.556

7.  Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease.

Authors:  Xiang Zou; Yifan Yuan; Yujun Liao; Conglin Jiang; Fan Zhao; Ding Ding; Yuxiang Gu; Liang Chen; Ying-Hua Chu; Yi-Cheng Hsu; Patrick Alexander Liebig; Bin Xu; Ying Mao
Journal:  Alzheimers Dement (N Y)       Date:  2022-04-06

Review 8.  Magnetic Resonance Imaging in Tauopathy Animal Models.

Authors:  Ruiqing Ni
Journal:  Front Aging Neurosci       Date:  2022-01-25       Impact factor: 5.750

9.  Cerebellar glutamatergic system impacts spontaneous motor recovery by regulating Gria1 expression.

Authors:  Pallavi Asthana; Gajendra Kumar; Lukasz M Milanowski; Ngan Pan Bennett Au; Siu Chung Chan; Jianpan Huang; Hemin Feng; Kin Ming Kwan; Jufang He; Kannie Wai Yan Chan; Zbigniew K Wszolek; Chi Him Eddie Ma
Journal:  NPJ Regen Med       Date:  2022-09-05

Review 10.  Saturation Transfer MRI for Detection of Metabolic and Microstructural Impairments Underlying Neurodegeneration in Alzheimer's Disease.

Authors:  Anna Orzyłowska; Wendy Oakden
Journal:  Brain Sci       Date:  2021-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.